TrialNCT05600036Phase 2Completed
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis
Study sponsor: Alumis Inc · ALMS
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2023-06-29Actual
Enrollment · participants228Actual
Source updated2025-06-18Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.